Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Equillium Inc.
Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
November 12, 2024
From
Equillium Inc.
Via
Business Wire
Tickers
EQ
Equillium Maintains Rights to Itolizumab Following Ono Partnership
October 31, 2024
From
Equillium Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights
August 08, 2024
From
Equillium Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata
June 04, 2024
From
Equillium Inc.
Via
Business Wire
Tickers
EQ
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
May 09, 2024
From
Equillium Inc.
Via
Business Wire
Tickers
EQ
Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium
October 16, 2023
From
Equillium Inc.
Via
Business Wire
Tickers
EQ
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today